CD44 receptor targeted nanoparticles augment immunity against tuberculosis in mice.
Singh VK, Chau E, Mishra A, DeAnda A, Hegde VL, Sastry JK, Haviland D, Jagannath C, Godin B, Khan A.
Singh VK, et al. Among authors: jagannath c.
J Control Release. 2022 Sep;349:796-811. doi: 10.1016/j.jconrel.2022.07.040. Epub 2022 Aug 3.
J Control Release. 2022.
PMID: 35914613
Free PMC article.